- Home
- ADAG vs OKYO Comparison
ADAG vs OKYO Comparison
Compare ADAG & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- OKYO
- Stock Information
- Founded
- ADAG 2011
- OKYO 2007
- Country
- ADAG China
- OKYO United Kingdom
- Employees
- ADAG N/A
- OKYO 4
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ADAG Health Care
- OKYO Health Care
- Exchange
- ADAG Nasdaq
- OKYO Nasdaq
- Market Cap
- ADAG 90.8M
- OKYO 95.3M
- IPO Year
- ADAG 2021
- OKYO 2022
- Fundamental
- Price
- ADAG $2.00
- OKYO $2.72
- Analyst Decision
- ADAG Strong Buy
- OKYO Strong Buy
- Analyst Count
- ADAG 1
- OKYO 1
- Target Price
- ADAG $8.00
- OKYO $7.00
- AVG Volume (30 Days)
- ADAG 94.7K
- OKYO 143.9K
- Earning Date
- ADAG 08-05-2025
- OKYO 08-12-2025
- Dividend Yield
- ADAG N/A
- OKYO N/A
- EPS Growth
- ADAG N/A
- OKYO N/A
- EPS
- ADAG N/A
- OKYO N/A
- Revenue
- ADAG $103,204.00
- OKYO N/A
- Revenue This Year
- ADAG $6,488.89
- OKYO N/A
- Revenue Next Year
- ADAG $57.50
- OKYO N/A
- P/E Ratio
- ADAG N/A
- OKYO N/A
- Revenue Growth
- ADAG N/A
- OKYO N/A
- 52 Week Low
- ADAG $1.33
- OKYO $0.81
- 52 Week High
- ADAG $3.58
- OKYO $3.28
- Technical
- Relative Strength Index (RSI)
- ADAG 56.27
- OKYO 48.76
- Support Level
- ADAG $1.87
- OKYO $2.67
- Resistance Level
- ADAG $2.17
- OKYO $2.85
- Average True Range (ATR)
- ADAG 0.17
- OKYO 0.24
- MACD
- ADAG 0.01
- OKYO -0.06
- Stochastic Oscillator
- ADAG 71.93
- OKYO 22.52
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.